Ghazi Kayali

InstitutionUniversity of Texas
AddressHouston
Texas
United States
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 10 Covid-19 publications, with a maximum of 2 publications in November 2020 and March 2021 and June 2021
    All Publications
    Bar chart showing 72 publications over 14 distinct years, with a maximum of 12 publications in 2016
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. El Rifay AS, Mahmoud SH, Marouf MA, Gomaa MR, El Taweel A, Abo Shama NM, GabAllah M, Abd El Dayem SM, Kandeil A, Mostafa A, El-Shesheny R, Kayali G, Ali MA. Determinants of having severe acute respiratory syndrome coronavirus 2 neutralizing antibodies in Egypt. Influenza Other Respir Viruses. 2021 11; 15(6):750-756. PMID: 34264010.
      Citations:    Fields:    Translation:Humans
    2. Kandeil A, Mostafa A, Kutkat O, Moatasim Y, Al-Karmalawy AA, Rashad AA, Kayed AE, Kayed AE, El-Shesheny R, Kayali G, Ali MA. Bioactive Polyphenolic Compounds Showing Strong Antiviral Activities against Severe Acute Respiratory Syndrome Coronavirus 2. Pathogens. 2021 Jun 15; 10(6). PMID: 34203977.
      Citations: 12     
    3. Fayad N, Abi Habib W, Kandeil A, El-Shesheny R, Kamel MN, Mourad Y, Mokhbat J, Kayali G, Goldstein J, Abdallah J. SARS-CoV-2 Variants in Lebanon: Evolution and Current Situation. Biology (Basel). 2021 Jun 14; 10(6). PMID: 34198622.
      Citations: 1     
    4. Gomaa MR, El Rifay AS, Shehata M, Shehata M, Kandeil A, Nabil Kamel M, Marouf MA, GabAllah M, El Taweel A, Kayed AE, Kutkat O, Moatasim Y, Mahmoud SH, Abo Shama NM, El Sayes M, Mostafa A, El-Shesheny R, McKenzie PP, Webby RJ, Kayali G, Ali MA. Incidence, household transmission, and neutralizing antibody seroprevalence of Coronavirus Disease 2019 in Egypt: Results of a community-based cohort. PLoS Pathog. 2021 03; 17(3):e1009413. PMID: 33705496.
      Citations: 4     Fields:    Translation:Humans
    5. Kandeil A, Mostafa A, Hegazy RR, El-Shesheny R, El Taweel A, Gomaa MR, Shehata M, Elbaset MA, Kayed AE, Mahmoud SH, Moatasim Y, Kutkat O, Yassen NN, Shabana ME, GabAllah M, Kamel MN, Abo Shama NM, El Sayes M, Ahmed AN, Elalfy ZS, Mohamed BM, Abd El-Fattah SN, El Hariri HM, Abdel Kader M, Azmy O, Kayali G, Ali MA. Immunogenicity and Safety of an Inactivated SARS-CoV-2 Vaccine: Preclinical Studies. Vaccines (Basel). 2021 Mar 03; 9(3). PMID: 33802467.
      Citations: 6     
    6. Mostafa A, Kandeil A, A M M Elshaier Y, Kutkat O, Moatasim Y, Rashad AA, Shehata M, Shehata M, Gomaa MR, Mahrous N, Mahmoud SH, GabAllah M, Abbas H, Taweel AE, Kayed AE, Kamel MN, Sayes ME, Mahmoud DB, El-Shesheny R, Kayali G, Ali MA. FDA-Approved Drugs with Potent In Vitro Antiviral Activity against Severe Acute Respiratory Syndrome Coronavirus 2. Pharmaceuticals (Basel). 2020 Dec 04; 13(12). PMID: 33291642.
      Citations: 23     
    7. Gomaa MR, Kandeil A, Mostafa A, Roshdy WH, Kayed AE, Shehata M, Shehata M, Kutkat O, Moatasim Y, El Taweel A, Mahmoud SH, Kamel MN, Abo Shama NM, El Sayes M, El-Shesheny R, Bakheet OH, Elgohary MA, Elbadry M, Nassif NN, Ahmed SH, Abdel Messih IY, Kayali G, Ali MA. Prevalence of Severe Acute Respiratory Syndrome Coronavirus 2 Neutralizing Antibodies in Egyptian Convalescent Plasma Donors. Front Microbiol. 2020; 11:596851. PMID: 33329484.
      Citations: 3     
    8. Roshdy WH, Rashed HA, Kandeil A, Mostafa A, Moatasim Y, Kutkat O, Abo Shama NM, Gomaa MR, El-Sayed IH, El Guindy NM, Naguib A, Kayali G, Ali MA. EGYVIR: An immunomodulatory herbal extract with potent antiviral activity against SARS-CoV-2. PLoS One. 2020; 15(11):e0241739. PMID: 33206688.
      Citations: 8     Fields:    Translation:HumansAnimalsCells
    9. Kandeil A, Gomaa MR, El Taweel A, Mostafa A, Shehata M, Shehata M, Kayed AE, Kutkat O, Moatasim Y, Mahmoud SH, Kamel MN, Shama NMA, El Sayes M, El-Shesheny R, Yassien MA, Webby RJ, Kayali G, Ali MA. Common childhood vaccines do not elicit a cross-reactive antibody response against SARS-CoV-2. PLoS One. 2020; 15(10):e0241471. PMID: 33112930.
      Citations: 1     Fields:    Translation:HumansAnimalsCellsPHPublic Health
    10. Mostafa A, Kandeil A, Shehata M, Shehata M, El Shesheny R, Samy AM, Kayali G, Ali MA. Middle East Respiratory Syndrome Coronavirus (MERS-CoV): State of the Science. Microorganisms. 2020 Jul 02; 8(7). PMID: 32630780.
      Citations: 9     
    11. Shehata MM, Kandeil A, Mostafa A, Mahmoud SH, Gomaa MR, El-Shesheny R, Webby R, Kayali G, Ali MA. A Recombinant Influenza A/H1N1 Carrying A Short Immunogenic Peptide of MERS-CoV as Bivalent Vaccine in BALB/c Mice. Pathogens. 2019 Dec 02; 8(4). PMID: 31810359.
      Citations: 2     
    12. Kandeil A, Gomaa M, Nageh A, Shehata MM, Kayed AE, Sabir JSM, Abiadh A, Jrijer J, Amr Z, Said MA, Byarugaba DK, Wabwire-Mangen F, Tugume T, Mohamed NS, Attar R, Hassan SM, Linjawi SA, Moatassim Y, Kutkat O, Mahmoud S, Bagato O, Shama NMA, El-Shesheny R, Mostafa A, Perera RA, Chu DK, Hassan N, Elsokary B, Saad A, Sobhy H, El Masry I, McKenzie PP, Webby RJ, Peiris M, Makonnen YJ, Ali MA, Kayali G. Middle East Respiratory Syndrome Coronavirus (MERS-CoV) in Dromedary Camels in Africa and Middle East. Viruses. 2019 08 05; 11(8). PMID: 31387326.
      Citations: 20     Fields:    Translation:AnimalsCellsPHPublic Health
    13. Shehata MM, Mostafa A, Teubner L, Mahmoud SH, Kandeil A, Elshesheny R, Frantz R, La Pietra L, Pleschka S, Osman A, Kayali G, Chakraborty T, Ali MA, Mraheil MA. Bacterial Outer Membrane Vesicles (OMVs)-based Dual Vaccine for Influenza A H1N1 Virus and MERS-CoV. Vaccines (Basel). 2019 05 28; 7(2). PMID: 31141982.
      Citations: 14     
    14. Kandeil A, Gomaa M, Shehata M, Shehata M, El-Taweel A, Kayed AE, Abiadh A, Jrijer J, Moatasim Y, Kutkat O, Bagato O, Mahmoud S, Mostafa A, El-Shesheny R, Perera RA, Ko RL, Hassan N, Elsokary B, Allal L, Saad A, Sobhy H, McKenzie PP, Webby RJ, Peiris M, Ali MA, Kayali G. Middle East respiratory syndrome coronavirus infection in non-camelid domestic mammals. Emerg Microbes Infect. 2019; 8(1):103-108. PMID: 30866764.
      Citations: 22     Fields:    Translation:HumansAnimalsCellsPHPublic Health
    15. Ali MA, Shehata MM, Gomaa MR, Kandeil A, El-Shesheny R, Kayed AS, El-Taweel AN, Atea M, Hassan N, Bagato O, Moatasim Y, Mahmoud SH, Kutkat O, Maatouq AM, Osman A, McKenzie PP, Webby RJ, Kayali G. Systematic, active surveillance for Middle East respiratory syndrome coronavirus in camels in Egypt. Emerg Microbes Infect. 2017 Jan 04; 6(1):e1. PMID: 28050021.
      Citations: 35     Fields:    Translation:AnimalsCellsPHPublic Health
    16. Kandeil A, Shehata MM, El Shesheny R, Gomaa MR, Ali MA, Kayali G. Complete Genome Sequence of Middle East Respiratory Syndrome Coronavirus Isolated from a Dromedary Camel in Egypt. Genome Announc. 2016 Apr 28; 4(2). PMID: 27125484.
      Citations: 10     
    17. Shehata MM, Gomaa MR, Ali MA, Kayali G. Middle East respiratory syndrome coronavirus: a comprehensive review. Front Med. 2016 Jun; 10(2):120-36. PMID: 26791756.
      Citations: 24     Fields:    Translation:HumansAnimalsCellsPHPublic Health
    18. Shehata MM, Chu DK, Gomaa MR, AbiSaid M, El Shesheny R, Kandeil A, Bagato O, Chan SM, Barbour EK, Shaib HS, McKenzie PP, Webby RJ, Ali MA, Peiris M, Kayali G. Surveillance for Coronaviruses in Bats, Lebanon and Egypt, 2013-2015. Emerg Infect Dis. 2016 Jan; 22(1):148-50. PMID: 26689887.
      Citations: 7     Fields:    Translation:AnimalsCells
    19. Crameri G, Durr PA, Barr J, Yu M, Graham K, Williams OJ, Kayali G, Smith D, Peiris M, Mackenzie JS, Wang LF. Absence of MERS-CoV antibodies in feral camels in Australia: Implications for the pathogen's origin and spread. One Health. 2015 Dec; 1:76-82. PMID: 28616468.
      Citations: 15     
    20. Kayali G, Peiris M. A more detailed picture of the epidemiology of Middle East respiratory syndrome coronavirus. Lancet Infect Dis. 2015 May; 15(5):495-7. PMID: 25863563.
      Citations: 21     Fields:    Translation:HumansAnimalsCells
    21. Zhao J, Perera RA, Kayali G, Meyerholz D, Perlman S, Peiris M. Passive immunotherapy with dromedary immune serum in an experimental animal model for Middle East respiratory syndrome coronavirus infection. J Virol. 2015 Jun; 89(11):6117-20. PMID: 25787284.
      Citations: 39     Fields:    Translation:AnimalsCells
    22. Chan RW, Hemida MG, Kayali G, Chu DK, Poon LL, Alnaeem A, Ali MA, Tao KP, Ng HY, Chan MC, Guan Y, Nicholls JM, Peiris JS. Tropism and replication of Middle East respiratory syndrome coronavirus from dromedary camels in the human respiratory tract: an in-vitro and ex-vivo study. Lancet Respir Med. 2014 Oct; 2(10):813-22. PMID: 25174549.
      Citations: 47     Fields:    Translation:HumansAnimalsCells
    23. Hemida MG, Perera RA, Al Jassim RA, Kayali G, Siu LY, Wang P, Chu KW, Perlman S, Ali MA, Alnaeem A, Guan Y, Poon LL, Saif L, Peiris M. Seroepidemiology of Middle East respiratory syndrome (MERS) coronavirus in Saudi Arabia (1993) and Australia (2014) and characterisation of assay specificity. Euro Surveill. 2014 Jun 12; 19(23). PMID: 24957744.
      Citations: 59     Fields:    Translation:HumansAnimalsCells
    24. Chu DK, Poon LL, Gomaa MM, Shehata MM, Perera RA, Abu Zeid D, El Rifay AS, Siu LY, Guan Y, Webby RJ, Ali MA, Peiris M, Kayali G. MERS coronaviruses in dromedary camels, Egypt. Emerg Infect Dis. 2014 Jun; 20(6):1049-53. PMID: 24856660.
      Citations: 156     Fields:    Translation:HumansAnimalsCells
    25. Perera RA, Wang P, Gomaa MR, El-Shesheny R, Kandeil A, Bagato O, Siu LY, Shehata MM, Kayed AS, Moatasim Y, Li M, Poon LL, Guan Y, Webby RJ, Ali MA, Peiris JS, Kayali G. Seroepidemiology for MERS coronavirus using microneutralisation and pseudoparticle virus neutralisation assays reveal a high prevalence of antibody in dromedary camels in Egypt, June 2013. Euro Surveill. 2013 Sep 05; 18(36):pii=20574. PMID: 24079378.
      Citations: 174     Fields:    Translation:HumansAnimalsCells
    26. Kayali G, Ortiz EJ, Chorazy ML, Gray GC. Lack of evidence of avian adenovirus infection among turkey workers. J Agromedicine. 2009; 14(3):299-305. PMID: 19657879.
      Citations: 1     Fields:    Translation:HumansAnimalsCellsPHPublic Health